%0 Journal Article
%A B.I. Eriksson
%A L. Borris
%A O.E. Dahl
%A W.D. Fisher
%A S. Haas
%A A.K. Kakkar
%A L.M. Kwong
%A F. Misselwitz
%A A.G. Turpie
%T RIVAROXABAN (BAY 59-7939) – A NOVEL, ORAL, DIRECT FACTOR XA INHIBITOR – FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER MAJOR ORTHOPAEDIC SURGERY: OVERVIEW OF THREE PHASE II TRIALS
%D 2009
%J Orthopaedic Proceedings
%P 103-104
%V 91-B
%N SUPP_I
%R 10.1302/0301-620X.91BSUPP_I.0910103d
%U https://doi.org/10.1302/0301-620X.91BSUPP_I.0910103d
%K